Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-27 @ 1:13 PM
Study NCT ID:
NCT06115135
Status:
RECRUITING
Last Update Posted:
2025-01-16
First Post:
2023-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Sponsor:
Oncotherapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-11
First Submit QC Date:
None
Study First Post Date:
2023-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-14
Last Update Post Date:
2025-01-16
Last Update Post Date Type:
ACTUAL